OpGen, Inc. Announces Expanded Adoption of Argus® Whole Genome Mapping System
11/19/2012 9:49:05 AM
GAITHERSBURG, Md.--(BUSINESS WIRE)--OpGen, Inc., a commercial stage DNA analysis company, today announced the Argus® Whole Genome Mapping System continues to gain broad adoption among genome sequencing centers worldwide. Five leading international genomic sequencing centers have joined the growing list of centers utilizing OpGen’s technology to enhance their next-generation sequencing capabilities. The centers include The Genome Institute at Washington University, St. Louis, MO; The Genome Analysis Centre (TGAC), Norwich, UK; Genoscope, Evry, France; National High-throughput DNA Sequencing Centre at the Centre for GeoGenetics, Copenhagen, Denmark; and Genome Institute of Singapore. These organizations join our growing customer base that includes Wellcome Trust Sanger Institute and BGI, public health and biodefense agencies, and research and service labs that are utilizing the company’s Whole Genome Mapping technologies and services.